| Whittington, D.A. (2024). Crystal structure of PRMT5:MEP50 in complex with MTA and oxamide compound 23. Protein Data Bank: 8veu. |
CMCF-ID |
PDB Deposition |
Health |
| Whittington, D.A. (2025). Crystal structure of truncated USP1:UAF1 in complex with compound 18. Protein Data Bank: 9n9y. |
CMCF-BM |
PDB Deposition |
Health |
| Whittington, D.A. (2025). Crystal structure of PRMT5:MEP50 in complex with MTA and oxamide compound 14. Protein Data Bank: 9n3o. |
CMCF-BM |
PDB Deposition |
Health |
| Whittington, D.A.; Epstein, L.F. (2016). B-Raf wild-type kinase domain in complex with a purinylpyridinylamino-based inhibitor. Protein Data Bank: 5fd2. |
CMCF-ID |
PDB Deposition |
Health |
| Whittington, D.A.; Epstein, L.F.; Chen, H. (2012). Crystal structure of human anaplastic lymphoma kinase in complex with piperidine-carboxamide inhibitor 2. Protein Data Bank: 4fnz. |
CMCF-ID |
PDB Deposition |
Health |
| Whittington, D.A.; Tang, J.; Yakowec, P. (2015). Crystal structure of human PI3K-gamma in complex with benzimidazole inhibitor 5. Protein Data Bank: 5eds. |
CMCF-ID |
PDB Deposition |
Health |
| Whittington, D.A.; Tang, J.; Yakowec, P. (2012). Crystal structure of human PI3K-gamma in complex with AMG511. Protein Data Bank: 4flh. |
CMCF-ID |
PDB Deposition |
Health |
| Wiewiora, Rafal Piotr (2021). Rigorous Construction of Markov State Models for Conformationally Selective Drug Design. Supervisor: Chodera, John D.. New York, United States: Weill Medical College of Cornell University. . |
CMCF-ID |
Doctoral Thesis |
Health |
| Wigle, Tim J.; Ren, Yue; Molina, Jennifer R.; Blackwell, Danielle J.; Schenkel, Laurie B. et al. (2021). Targeted Degradation of PARP14 Using a Heterobifunctional Small Molecule. ChemBioChem 22(12) . 10.1002/cbic.202100047. [PDB: 7l9y] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Wilding, Birgit; Scharn, Dirk; Böse, Dietrich; Baum, Anke; Santoro, Valeria et al. (2022). Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling. Nature Cancer 3(7) , 821-836. 10.1038/s43018-022-00412-y. [PDB: 7pcd] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Williams, S.P.; Kahler, K.M.; Shotwell, J.B. (2013). HCV NS5B GT1A C316Y with GSK5852. Protein Data Bank: 4khr. |
CMCF-ID |
PDB Deposition |
Health |
| Williams, S.P.; Kahler, K.; Price, D.J.; Peat, A.J. (2019). HCV NS5B 1A Y316 bound to Compound 49. Protein Data Bank: 6mvo. |
CMCF-ID |
PDB Deposition |
Health |
| Wilsbacher, Julie L.; Cheng, Min; Cheng, Dong; Trammell, Samuel A.J.; Shi, Yan et al. (2017). Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors. Molecular Cancer Therapeutics 16(7) , 1236-1245. 10.1158/1535-7163.mct-16-0819. [PDB: 5u2m] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Wiseman, Ben; Carpena, Xavi; Feliz, Miguel; Donald, Lynda J.; Pons, Miquel et al. (2010). Isonicotinic Acid Hydrazide Conversion to Isonicotinyl-NAD by Catalase-peroxidases. Journal of Biological Chemistry 285(34) , 26662-26673. 10.1074/jbc.m110.139428. [PDB: 5sxq, 5sxr, 5sxs, 5sxt, 5sxw, 5sxx] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Wong, A.H.; Rini, J.M. (2017). Crystal structure of the human coronavirus 229E spike protein receptor binding domain in complex with human aminopeptidase N. Protein Data Bank: 6atk. |
CMCF-ID |
PDB Deposition |
Health |